Das Klinikum
Dr. med. Anja Schork
Funktionsoberärztin
Kontakt
Telefonnummer: Sekretariat Nephrologie: 07071 29-83172
Telefonnummer: Geschäftsstelle Transplantationszentrum: 07071/29-86600
E-Mail-Adresse: anja.schork@med.uni-tuebingen.de
Klinik / Institut / Zentrum
Klinische Schwerpunkte
- Innere Medizin und Nephrologie
Wissenschaftliche Tätigkeit
- Randomized, controlled interventional trial to investigate the efficacy of amiloride for the treatment of edema in human nephrotic syndrome (AMILOR study, EudraCT Number 2019-002607-18)
- Messung der Köperzusammensetzung und des Volumenstatus mit dem Body Composition Monitor (BCM) bei Patienten mit chronischer Niereninsuffizienz und unter Behandlung mit SGLT2-Inhibitoren
Preise & Auszeichnungen
- Dietrich Plester Promotionspreis der Medizinischen Fakultät Tübingen 2017
- Abstract-Preis 2018, 10. Jahrestagung der Dt. Gesellschaft für Nephrologie
Publikationen
- Schork A, Fritsche A, Schleicher ED, Peter A, Heni M, Stefan N, von Schwartzenberg RJ, Guthoff M, Mischak H, Siwy J, Birkenfeld AL, Wagner R. Differential risk assessment in persons at risk of type 2 diabetes using urinary peptidomics. Metabolism. 2025 Jun;167:156174. doi: 10.1016/j.metabol.2025.156174. Epub 2025 Feb 27. PMID: 40023439.
- Schork A, Eberbach ML, Artunc F, Bohnert BN, Eisinger F, Heister DJ, Vosseler D, Nadalin S, Birkenfeld AL, Heyne N, Guthoff M. SGLT2 Inhibitors Correct Fluid Overload in Adult Kidney Transplant Recipients-A Prospective Observational Study. Transpl Int. 2024 Jun 10;37:12879. doi: 10.3389/ti.2024.12879. PMID: 38915756; PMCID: PMC11194332.
- Schork A, Vogel E, Bohnert BN, Essigke D, Wörn M, Fischer I, Heyne N, Birkenfeld AL, Artunc F. Amiloride versus furosemide for the treatment of edema in patients with nephrotic syndrome: A pilot study (AMILOR). Acta Physiol (Oxf). 2024 Aug;240(8):e14183. doi: 10.1111/apha.14183. Epub 2024 Jun 1. PMID: 38822593.
- Schork A, Eberbach ML, Bohnert BN, Wörn M, Heister DJ, Eisinger F, Vogel E, Heyne N, Birkenfeld AL, Artunc F. SGLT2 Inhibitors Decrease Overhydration and Proteasuria in Patients with Chronic Kidney Disease: A Longitudinal Observational Study. Kidney Blood Press Res. 2024;49(1):124-134. doi: 10.1159/000535643. Epub 2024 Jan 16. PMID: 38228104; PMCID: PMC10885839.
- Schork A, Bohnert BN, Heyne N, Birkenfeld AL, Artunc F. Overhydration Measured by Bioimpedance Spectroscopy and Urinary Serine Protease Activity Are Risk Factors for Progression of Chronic Kidney Disease. Kidney Blood Press Res. 2020;45(6):955-68. Epub 2020/12/03. doi: 10.1159/000510649. PubMed PMID: 33264776.
- Schork A, Saynisch J, Vosseler A, Jaghutriz BA, Heyne N, Peter A, et al. Effect of SGLT2 inhibitors on body composition, fluid status and renin-angiotensin-aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy. Cardiovasc Diabetol. 2019;18(1):46. Epub 2019/04/07. doi: 10.1186/s12933-019-0852-y. PubMed PMID: 30953516; PubMed Central PMCID: PMCPMC6451223.
- Artunc F, Wörn M, Schork A, Bohnert BN. Proteasuria-The impact of active urinary proteases on sodium retention in nephrotic syndrome. Acta Physiol (Oxf). 2019;225(4):e13249. Epub 2019/01/01. doi: 10.1111/apha.13249. PubMed PMID: 30597733
- Haerteis S, Schork A, Dörffel T, Bohnert BN, Nacken R, Wörn M, et al. Plasma kallikrein activates the epithelial sodium channel in vitro but is not essential for volume retention in nephrotic mice. Acta Physiol (Oxf). 2018;224(1):e13060. Epub 2018/03/01. doi: 10.1111/apha.13060. PubMed PMID: 29489063.
- Schork A, Woern M, Kalbacher H, Voelter W, Nacken R, Bertog M, et al. Association of Plasminuria with Overhydration in Patients with CKD. Clin J Am Soc Nephrol. 2016;11(5):761-9. Epub 2016/03/05. doi: 10.2215/cjn.12261115. PubMed PMID: 26933188; PubMed Central PMCID: PMCPMC4858495.
- Publikationen